Sign In
Buy ALLK
$0.329
+0 (+0%)
At Close: Aug 14, 2025
Why Allakos Stock Is on Fire Today
02:10pm, Wednesday, 31'st Aug 2022
Investors appear to be getting into position ahead of a major upcoming catalyst.
A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street
10:38am, Monday, 09'th May 2022 Benzinga
Pre-open movers
U.S. stock futures traded lower in early pre-market trade after the Dow Jones dropped around 100 points in the previous session. Investors are awaiting earnings results from Exelon Co
5 Stocks To Watch For May 9, 2022
09:07am, Monday, 09'th May 2022 Benzinga
Some of the stocks that may grab investor focus today are:
Wall Street expects Exelon Corporation (NASDAQ: EXC) to report quarterly earnings at $0.66 per share on revenue of $4.62 billion before the
Allakos Provides Business Update and Reports First Quarter 2022 Financial Results
08:05pm, Friday, 06'th May 2022 GlobeNewswire Inc.
REDWOOD CITY, Calif., May 06, 2022 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) and AK006 for the treatment of allergi
Allakos Inc. (ALLK) Stock Sinks As Market Gains: What You Should Know
10:00pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Allakos Inc. (ALLK) closed at $3.86 in the latest trading session, marking a -1.03% move from the prior day.
Allakos Inc. (ALLK) Stock Moves -1.6%: What You Should Know
10:00pm, Friday, 22'nd Apr 2022 Zacks Investment Research
Allakos Inc. (ALLK) closed the most recent trading day at $4.31, moving -1.6% from the previous trading session.
Allakos Inc. (ALLK) Stock Sinks As Market Gains: What You Should Know
10:15pm, Tuesday, 19'th Apr 2022 Zacks Investment Research
In the latest trading session, Allakos Inc. (ALLK) closed at $4.80, marking a -1.64% move from the previous day.
Allakos Inc. (ALLK) Gains As Market Dips: What You Should Know
10:15pm, Tuesday, 12'th Apr 2022 Zacks Investment Research
In the latest trading session, Allakos Inc. (ALLK) closed at $5.46, marking a +0.18% move from the previous day.
Allakos Inc. (ALLK) Stock Sinks As Market Gains: What You Should Know
10:15pm, Monday, 28'th Mar 2022 Zacks Investment Research
Allakos Inc. (ALLK) closed the most recent trading day at $5.69, moving -0.52% from the previous trading session.
Allakos Inc. (ALLK) Outpaces Stock Market Gains: What You Should Know
10:15pm, Tuesday, 22'nd Mar 2022 Zacks Investment Research
Allakos Inc. (ALLK) closed at $5.97 in the latest trading session, marking a +1.7% move from the prior day.
Allakos Inc. (ALLK) Stock Sinks As Market Gains: What You Should Know
10:00pm, Tuesday, 15'th Mar 2022 Zacks Investment Research
Allakos Inc. (ALLK) closed at $5.08 in the latest trading session, marking a -0.39% move from the prior day.
Why Allakos Stock Sank 17.3% in February
03:39pm, Monday, 07'th Mar 2022 The Motley Fool
The biotech stock has lost roughly 96% of its value over the last year.
Why Allakos Stock Sank 17.3% in February
10:39am, Monday, 07'th Mar 2022
The biotech stock has lost roughly 96% of its value over the last year.
Allakos GAAP EPS of -$1.73 misses by $0.38
09:58pm, Tuesday, 01'st Mar 2022 Seeking Alpha
Allakos press release (ALLK): Q4 GAAP EPS of -$1.73 misses by $0.38.Allakos ended the fourth quarter of 2021 with $424.2 million in cash, cash equivalents and marketable securities.
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
09:05pm, Tuesday, 01'st Mar 2022 GlobeNewswire Inc.
REDWOOD CITY, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) and AK006 for the treatment of aller
